In patients who used used anti-TNF agents and developed TB, disease distribution was as follows: ankylosing spondylitis 23 (48.9%), rheumatoid arthritis 13 (27.7%), Behçet’s syndrome 8 (17%) and psoriatic arthritis 3 (6.4%). This evidence concerns the gene TNF and psoriatic arthritis.